kff employer health benefits survey 2025 glp-1 coverage In 2025: Family Premiums Rise 6 Percent, Large Employers Increase Of GLP-1s For Weight Loss Satisfaction With Healthcare Coverage Spread

Hormonal and blood-sugar disruption, including elevated cortisol and prolactin, reduced insulin sensitivity, and hypoglycemia risk tied to IGF-1 receptor activity

For patients in Laurel and surrounding Maryland communities, an evaluation may help place semaglutide or tirzepatide in the context of nutrition, lifestyle, body composition, metabolic factors, and previous weight-loss attempts

Suicidal Ideation and Other Rare Undesirable Effects With the expanding role in diabetes and obesity, as well as potential extending therapeutic uses in the neurological area (e.g., stroke, neurodegenerative disorders, alcohol- and substance-use disorders), rare side effects have recently emerged

It may be administered safely for longer periods, as well

Tirzepatide safety data Tirzepatide safety data comes from the SURPASS and SURMOUNT trial programs involving thousands of subjects

But is that the type of thing youd be potentially studying